ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] (2023)
Gurnari, Carmelo; Prata, Pedro Henrique de Lima; Catto, Luiz Fernando Bazzo ; Durmaz, Arda; Pinto, André Luiz; Inacio, Mariana Carolina Beraldo; Hernandez, Lucie; Dhedin, Nathalie; Visconte, Valeria; Soulier, Jean; Calado, Rodrigo Tocantins
Fonte: Blood. Unidade: FMRP
Assuntos: ANEMIA, NEOPLASIAS, DOENÇAS RARAS, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GURNARI, Carmelo et al. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood.2023020108. Acesso em: 24 out. 2025. , 2023
APA
Gurnari, C., Prata, P. H. de L., Catto, L. F. B., Durmaz, A., Pinto, A. L., Inacio, M. C. B., et al. (2023). IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood.2023020108
NLM
Gurnari C, Prata PH de L, Catto LFB, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Visconte V, Soulier J, Calado RT. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] [Internet]. Blood. 2023 ; 141( 25): 3122-3125.[citado 2025 out. 24 ] Available from: https://doi.org/10.1182/blood.2023020108
Vancouver
Gurnari C, Prata PH de L, Catto LFB, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Visconte V, Soulier J, Calado RT. IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria [Carta] [Internet]. Blood. 2023 ; 141( 25): 3122-3125.[citado 2025 out. 24 ] Available from: https://doi.org/10.1182/blood.2023020108
Artigo de periodico
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 (2014)
Campos, Paula de Melo; Machado Neto, João Agostinho ; Scopim-Ribeiro, Renata; Visconte, Valeria; Tabarroki, Ali; Duarte, Adriana S. S; Barra, Flávia F. C; Vassalo, José; Rogers, Heesun J; Lorand-Metze, Irene; Tiu, Ramon V; Costa, Fernando F; Saad, Sara T. Olalla; Traina, Fabiola
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: APOPTOSE (EFEITOS DE DROGAS), PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Paula de Melo et al. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research, v. 38, n. 10, p. 1245-1251, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2014.07.010. Acesso em: 24 out. 2025.
APA
Campos, P. de M., Machado Neto, J. A., Scopim-Ribeiro, R., Visconte, V., Tabarroki, A., Duarte, A. S. S., et al. (2014). Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research, 38( 10), 1245-1251. doi:10.1016/j.leukres.2014.07.010
NLM
Campos P de M, Machado Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte ASS, Barra FFC, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Saad STO, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 [Internet]. Leukemia Research. 2014 ; 38( 10): 1245-1251.[citado 2025 out. 24 ] Available from: https://doi.org/10.1016/j.leukres.2014.07.010
Vancouver
Campos P de M, Machado Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte ASS, Barra FFC, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Saad STO, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 [Internet]. Leukemia Research. 2014 ; 38( 10): 1245-1251.[citado 2025 out. 24 ] Available from: https://doi.org/10.1016/j.leukres.2014.07.010
Artigo de periodico-carta/editorial
SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype (2013)
Visconte, Valeria; Tabarroki, Ali; Rogers, Heesun J.; Hasrouni, Edy; Traina, Fabiola; Makishima, Hideki; Hamilton, Betty K.; Liu, Yang; O'Keefe, Christine; Lichtin, Alan; Horwitz, Leonard; Sekeres, Mikkael A.; Hsieh, Fred H.; Tiu, Ramon V.
Fonte: Haematologica. Unidade: FMRP
Assuntos: HEMATOLOGIA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VISCONTE, Valeria et al. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3324/haematol.2013.090506. Acesso em: 24 out. 2025. , 2013
APA
Visconte, V., Tabarroki, A., Rogers, H. J., Hasrouni, E., Traina, F., Makishima, H., et al. (2013). SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3324/haematol.2013.090506
NLM
Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype [Internet]. Haematologica. 2013 ; 98( 9): e105-e107.[citado 2025 out. 24 ] Available from: https://doi.org/10.3324/haematol.2013.090506
Vancouver
Visconte V, Tabarroki A, Rogers HJ, Hasrouni E, Traina F, Makishima H, Hamilton BK, Liu Y, O'Keefe C, Lichtin A, Horwitz L, Sekeres MA, Hsieh FH, Tiu RV. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype [Internet]. Haematologica. 2013 ; 98( 9): e105-e107.[citado 2025 out. 24 ] Available from: https://doi.org/10.3324/haematol.2013.090506

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em

Afiliação dos autores externos não normalizada